
Free Daily Podcast Summary
by Human Content, Inc.
Healthcare is changing at breakneck speed, and let's face it, staying informed is getting harder by the day. If only there were a way to get the industry news you need in less time than it takes to get prior auth approved. (Spoiler: There is.) Every Friday, start your day with Dr. Will Flanary (aka Dr. Glaucomflecken), Dr. Alok Patel, Dr. Jen Lincoln, Adam Rose, and Eva Johnson as they bring you the week's most important headlines across clinical care, health policy, groundbreaking publications, medical pop culture, and more. Presented with clear, unbiased, fact-first reporting made strictly for healthcare professionals, by healthcare professionals. Prepare to wow your colleagues with how informed you are, all without risking another evening doom-scrolling through 5% actual news and 95% videos of, well, if you know you know. Medicine moves fast... So do we!
The most recent episodes — sign up to get AI-powered summaries of each one.
Friday, November 20, 2026 In today's episode, Dr. Jennifer Lincoln (@drjenniferlincoln) & Adam Rose (@adjoro) cover the U.S. losing its measles elimination status. They explain what elimination means, why the status lapsed after 26 years, and what reinstatement would take. They also break down the FDA approval of asundexian, the first factor XIa inhibitor, for secondary stroke prevention. Plus: they discuss a new Medicare code for vaccine adverse event care, a brain implant that helped a former singer with ALS sing again, a viral Saturday Night Live skit that tackles senior care, and more. Coverage Timeline: Intro Measles Makes a Comeback A New Pill For Stroke Prevention SNL Takes on Caregiving Brain Implants Bring Back Voices Coming Next: Behind the Burnout Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com. Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production
Friday, November 13, 2026 In today's episode, Dr. Jennifer Lincoln (@drjenniferlincoln) & Eva Johnson cover two large heart drug trials that lowered markers but not events. They break down Lp(a)HORIZON, which tested pelacarsen, and ZEUS, which tested ziltivekimab. They explain why moving a risk marker is not the same as changing outcomes. Plus: they also discuss an FDA investigation into tumors after the SMA gene therapy Zolgensma, what monitoring may mean for practice, an NFL star's scary neck injury, and more. Coverage Timeline: This Week’s Headlines Pelacarsen: Big Drop, No Benefit ZEUS Falls Flat Gene Therapy’s Tumor Risk Plasma Hack, AI Prior Auth & Statin Nudges Jack Campbell’s Recovery Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com. Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production
Friday, November 6, 2026 In today's episode, Dr. Will Flanary (@drglaucomflecken) & Adam Rose (@adjoro) cover a new JAMA Network Open estimate that 74.5 percent of deceased former NFL players had CTE after correcting for brain bank selection bias. They break down how researchers modeled donation bias and why the finding still cannot estimate risk for living players. They also dig into how the NFL and players association responded and what it means for counseling patients on head injury risk. Plus: they also discuss the 2026 midterm election results in which several doctors won their races, CVS splitting up, a major dialysis trial that stopped early, and more. Coverage Timeline: Intro CTE Among Former NFL Players French ICU Dialysis Trial 2026 Midterm Result CVS Health Split Phone Location Data Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com. Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production
Friday, October 30, 2026 In today's episode, Dr. Jennifer Lincoln (@drjenniferlincoln) & Eva Johnson cover full phase three results for a Lyme disease vaccine, and Psychiatry Boot Camp host Dr. Mark Mullen pays a visit. They break down a new once monthly olanzapine shot for schizophrenia. Plus: a dementia study built on a 1972 British school reform, why Christina Applegate says her MS diagnosis was wrong, and GLP-1 drugs may affect drinking habits in the UK. Thank you to guest anchor Dr. Mark Mullen! Check out his podcast Psychiatry Boot Camp, available every other Monday on YouTube and all your favorite podcast apps. To learn more, visit psychiatrybootcamp.com Coverage Timeline: Intro Lyme Disease Vaccine Vaccine Safety & History Schizophrenia Treatment School & Dementia Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com. Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production
Friday, October 23, 2026 In today's episode, Dr. Alok Patel (@alokpatelmd) & Adam Rose (@adjoro) cover a phase three trial of nicotinamide riboside in early Parkinson disease. Over 52 weeks, the supplement boosted NAD metabolism but showed no clinical benefit, raising questions for NAD boosting strategies. They also walk through a large hospital comparison of phenobarbital and diazepam for alcohol withdrawal, with similar stays and ventilation rates and fewer self directed discharges on phenobarbital, and why diazepam protocols may stay the course pending randomized trials. Plus: they also discuss national measles trends, FDA warning letters to Amazon and Walmart, and more. Coverage Timeline: Intro NR Supplement Trial for Parkinson's NAD Supplements & Influencer Hype Phenobarbital vs. Diazepam Measles Surge in US New Sunscreen Ingredient BEMT Blood Clots Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com. Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production
Friday, October 16, 2026 In today's episode, Dr. Alok Patel (@alokpatelmd) & Eva Johnson cover the FDA clearance of Motivista as the first prescription app for negative symptoms of schizophrenia. They break down the 16 week CONVOKE trial and what a 2.6 point edge over a control app means for stable patients on antipsychotics. They also review new ACP guidance placing menopausal hormone therapy first for hot flashes and night sweats, with second and third line options. Plus: they discuss early feasibility data on a medical AI chatbot for pre visit histories, new federal recommendations on concentrated kratom products, and more. Coverage Timeline: Intro Schizophrenia App Cleared Hot Flashes Guidance Dogs & Sleep Study AI In Urgent Care Awards & Dahlias Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com. Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production
Friday, October 9, 2026 In today's episode, Dr. Will Flanary (@drglaucomflecken) & Adam Rose (@adjoro) cover Phase 3 results for retatrutide with up to 28.3% average weight loss at 80 weeks. They explain dosing, tolerability and what remains unproven for heart and kidney outcomes and how retatrutide compares with current GLP-1 options. They also break down a federal proposal to modernize airline emergency kits around nine life threatening categories with airline level discretion. Plus: they discuss a growing pediatric heart valve, the return of Doc, Best Medicine, Chicago Med and Grey’s Anatomy, and more. Coverage Timeline: Intro Retatrutide Weight Loss Trial FAA Airline Medical Kits Growing Heart Valve Fasting Before Blood Work Medical Drama Premieres Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit https://www.medlinespod.com or email medlines@human-content.com. Sources & Media Attributions for Today's Episode Available At: https://www.medlinespod.com/sources Medlines is a Human Content Production
Friday, October 2, 2026 In today's episode, Dr. Jennifer Lincoln (@drjenniferlincoln) joins Medlines as a new anchor! She and Eva Johnson cover an FDA advisory panel vote on an early cancer detection blood test for adults 50 and older. The panel called the test safe, then split on whether it works. The agency still has to rule. They also walk through a UCSF comparison of myomectomy and radiofrequency ablation for uterine fibroids. Both treatments improved symptoms over two years, and neither difference reached the study threshold for a clinically important advantage. Plus: new findings on animal therapy, and more. Coverage Timeline: Intro FDA Backs Multi-Cancer Blood Test Uterine Fibroids: Surgery vs. Heat Therapy Gambling ER Visits Surge Miniature Horses Lift Teen Mood Have a story, think we missed something, want to say hi, or curious to learn about the Medlines team? Visit www.medlinespod.com or email medlines@human-content.com. Sources & Media Attributions for Today's Episode Available At: www.medlinespod.com/sources Medlines is a Human Content Production
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
Listeners also like.

Health vs Hype with the American Medical Association
A medical expert debunks viral health trends and misinformation with science-backed insights from physicians.

Health Matters
NewYork-Presbyterian

Frankly Speaking About Family Medicine
Discusses current topics and developments in primary care and family medicine.

Red Pill Your Healthcast
Two healthcare providers discuss overlooked health issues and empower listeners to make informed decisions for their families.

HEALTH TALK AMERICA
Doctors discuss functional medicine, wellness, and health research, offering practical advice for listeners to improve their well-being.

The Curbsiders Internal Medicine Podcast
Expert-led internal medicine discussions with clinical insights and humor for primary care and hospital medicine providers.

The House of Pod
A gastrointestinal doctor and colleagues discuss medicine with humor and insight.

Plenary Session
A medical podcast exploring oncology, health policy, and evidence-based medicine through expert discussions.

The Dr. Hyman Show
Explores root causes of chronic disease and promotes functional medicine, nutrition, and preventive health through expert discussions.

The VPZD Show
Two physicians discuss healthcare, medicine, and policy from a contrarian, middle-ground perspective.

The Pulse
Explores surprising stories in health and science, from operating rooms and labs to breakthrough innovations.

Treated with Dr. Sara Szal
Dr. Sara Szal explores holistic health solutions through conversations with experts and patients seeking mind, body, and soul healing.
Healthcare is changing at breakneck speed, and let's face it, staying informed is getting harder by the day. If only there were a way to get the industry news you need in less time than it takes to get prior auth approved. (Spoiler: There is.) Every Friday, start your day with Dr. Will Flanary (aka Dr. Glaucomflecken), Dr. Alok Patel, Dr. Jen Lincoln, Adam Rose, and Eva Johnson as they bring you the week's most important headlines across clinical care, health policy, groundbreaking publications, medical pop culture, and more. Presented with clear, unbiased, fact-first reporting made strictly for healthcare professionals, by healthcare professionals. Prepare to wow your colleagues with how informed you are, all without risking another evening doom-scrolling through 5% actual news and 95% videos of, well, if you know you know. Medicine moves fast... So do we!
AI-powered recaps with compact key takeaways, quotes, and insights.
Get key takeaways from Medlines in a 5-minute read.
Stay current on your favorite podcasts without falling behind.
It's a free AI-powered email that summarizes new episodes of Medlines as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Human Content, Inc..
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
Medlines publishes weekly. Our AI generates a summary within hours of each new episode.
Medlines covers topics including Science, News, Medicine, Fitness, Commentary, Health & Fitness, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.